Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Hematology, Transfusion and Cell Therapy|September 23, 2020
Exploring redox vulnerabilities in JAK2V617F-positive cellular modelsKeli Lima, Lucia Rossetti Lopes, João Agostinho Machado-Neto
Cancers|December 23, 2022
Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic NeoplasmsHugo Passos Vicari, Keli Lima, Leticia Veras Costa-Lotufo, et al.
Biochemical Society Transactions|September 22, 2025
New molecular targets in acute leukemias: cytoskeletal regulatory proteinsJoão Agostinho Machado-Neto, Hugo Passos Vicari, Jean Carlos Lipreri da Silva, et al.
Investigational New Drugs|January 21, 2021
AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axisJorge Antonio Elias Godoy Carlos, Keli Lima, Leticia Veras Costa-Lotufo, et al.
ACS Omega|August 18, 2025
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3H)‑ones as Potential Antileukemic AgentsGiorgio Antoniolli, Keli Lima, Gilberto Carlos Franchi, et al.
Hematology, Transfusion and Cell Therapy|September 11, 2024
The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cellsJorge Antonio Elias Godoy Carlos, Keli Lima, Eduardo Magalhães Rego, et al.
Translational Cancer Research|December 19, 2024
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapesJoão Agostinho Machado-Neto, Hugo Passos Vicari, Jean Carlos Lipreri da Silva, et al.
Scientific Reports|October 12, 2022
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cellsLívia Bassani Lins de Miranda, Keli Lima, Juan Luiz Coelho-Silva, et al.
Hematology, Transfusion and Cell Therapy|March 24, 2024
NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myelomaGustavo Nery de Queiroz, Keli Lima, Livia Bassani Lins de Miranda, et al.
Translational Cancer Research|May 25, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategiesJuan Luiz Coelho-Silva, Natália Sudan Parducci, Maria Fernanda Lopes Carvalho, et al.
Pageof 5